JPRN-UMIN000007138已完成2 期
Phase II study of first line chemotherapy with UFT/LV in elderly patients with advanced/recurrent colorectal cancer. - Phase II study of first line chemotherapy with UFT/LV in elderly patients with advanced/recurrent colorectal cancer.
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group0 个研究点目标入组 30 人开始时间: 2012年1月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Interstitial pneumoni, fibroid lung 2) Massive pleural or abdominal effusion 3) Patients with active synchronous or metachronous malignancy other than carcinoma in situ 4) Infection, intestinal paralysis / enterostasis 5) Watery stools or diarrhea 6) Uncontrolled diabetes mellitus 7) Severe complications 8) Metastasis to CNS 9) Pregnant or lactating woman 10) History of the severe hypersensitivity 11) Other patients who are unfit for the study as determined by the attending physician.
研究者
相似试验
已完成
不适用
Phase I/II study of first line chemotherapy with TS-1 in elderly patients with advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000002994Kagawa TGO Study Group45
已完成
2 期
Phase II study of chemotherapy with UFT/LV/Bevacizumab in elderly patients with advanced and recurrent colorectal cancer.advanced and recurrent colorectal cancerJPRN-UMIN000003447Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group40
进行中（未招募）
不适用
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumors of the oro- , hypopharynx and larynxTPF-C-HIT-Study - TPF-C-HITThe study is a phase II study of induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumors of the oro- , hypopharynx and laynx (TPF-C-HIT-Study)EUCTR2009-016489-10-DEniversity of Heidelberg
已完成
2 期
A phase II study of first line chemotherapy by eribulin mesilate for HER2 negative recurrent breast cancerBreast cancerJPRN-UMIN000007990Kobe Breast Cancer Oncology Group35
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50